PITTSBURGH, Oct. 13, 2021 /PRNewswire/
-- Viatris Inc. (NASDAQ: VTRS) plans to release its third
quarter 2021 financial results on Monday,
Nov. 8, before the open of the U.S. financial markets. Chief
Executive Officer Michael Goettler, President Rajiv Malik
and Chief Financial Officer Sanjeev Narula also will host a
webcast at 10 a.m. ET on Nov. 8 to discuss the results.
Investors and the general public are invited to listen to a live
webcast of the call at investor.viatris.com or by calling
866.342.8591 or 203.518.9713 for international callers (Conference
ID: VTRSQ321). A replay of the webcast also will be available
on the website.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a new kind of healthcare
company, empowering people worldwide to live healthier at every
stage of life. We provide access to medicines, advance
sustainable operations, develop
innovative solutions and leverage our
collective expertise to connect more people to more
products and services through our one-of-a-kind Global
Healthcare Gateway®. Formed in November
2020, Viatris brings together scientific, manufacturing
and distribution expertise with proven
regulatory, medical and commercial capabilities to
deliver high-quality medicines to patients in more than 165
countries and territories. Viatris' portfolio comprises more
than 1,400 approved molecules across a wide range of therapeutic
areas, spanning both non-communicable and infectious diseases,
including globally recognized brands, complex generic and branded
medicines, a growing portfolio of biosimilars and a variety of
over-the-counter consumer products. With a global workforce
of more than 40,000, Viatris is headquartered in the
U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at
viatris.com and investor.viatris.com, and connect with us on
Twitter
at @ViatrisInc, LinkedIn and YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-inc-to-release-third-quarter-2021-financial-results-on-nov-8-2021-301399098.html
SOURCE Viatris Inc.